Okay, Computer: AI Ate the Nasdaq with Jeff Richards and Rick Heitzmann
RiskReversal Pod
00:00
The Future of Corporate VC
Roxanne Jones: Let's talk about the Roe Body program. What drew you to this, I think you're going to call it a mega trend? She says there is so much excitement around these GLP ones that were originally FDA approved for diabetes and for pre-diabetics but also they found that this is just an amazing weight loss drug. Jones: It really was the pandemic, I think, that highlighted the benefits of these models. And now we're seeing it as they want to verticalize around some of these, again, this weight loss.
Play episode from 49:15
Transcript
